Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.

MLA

Koichi Miyata, et al. “Infliximab for Intensification of Primary Therapy for Patients with Kawasaki Disease and Coronary Artery Aneurysms at Diagnosis.” Archives of Disease in Childhood, vol. 108, no. 9, Sept. 2023, pp. 833–38. EBSCOhost, https://doi.org/10.1136/archdischild-2023-325639.

APA

Koichi Miyata, Bainto, E. V., Xiaoying Sun, Jain, S., Dummer, K. B., Burns, J. C., & Tremoulet, A. H. (2023). Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis. Archives of Disease in Childhood, 108(9), 833–838. https://doi.org/10.1136/archdischild-2023-325639

Chicago

Koichi Miyata, Emelia V. Bainto, Xiaoying Sun, Sonia Jain, Kirsten B. Dummer, Jane C. Burns, and Adriana H. Tremoulet. 2023. “Infliximab for Intensification of Primary Therapy for Patients with Kawasaki Disease and Coronary Artery Aneurysms at Diagnosis.” Archives of Disease in Childhood 108 (9): 833–38. doi:10.1136/archdischild-2023-325639.